Compliant Qualification and use of Reference Standards in Quality Control

Participants learn about GMP requirements, reference standards, practical orientation, and recommendations for characterization, use, maintenance, and retesting. They also discuss uncertainty implications for mass balance approach and collaborative assay design.
IMG Joachim Ermer
Webinar Id: 60034
Recorded
Session
$159.00
Single Attendee
$359.00
Group Attendees

Overview:

Reference standards are an essential part of many analytical procedures in pharmaceutical analysis, and their integrity is pivotal for the accuracy of results. The suitability for their use should never be underrated, in particular if quantitative, as reference standards are often used for a long time, and many released batches of API or drug products may be affected in case of problems. Therefore, a thorough characterization, in particular the content assignment (if relevant), a complete documentation, an appropriate storage and monitoring of their stability is of utmost importance.

Compendia do not only provide official reference standards within the scope of their monographs and general chapters, but establish also comprehensive information, discussion, and requirements with respect to their characterization, maintenance, and use. This can also be taken as orientation for internal reference standards, in order to prepare for regulatory submissions, as well as for inspections and audits.

Why you should Attend:

Participants will gain an overview on GMP and compendial requirements with respect to reference standards, as well as practical orientation and recommendations concerning appropriate characterization, use and maintenance, as well as establishment of a retest period. Due to its impact, the content assignment is discussed in detail, including the corresponding uncertainty implications with respect to the mass balance approach and (collaborative) assay design. 

Areas Covered in the Session:

  • Regulatory requirements to pharmaceutical reference standards
  • Compendial standards (USP, Ph.Eur., JP)
  • Characterization (Guidelines FDA, ICH, WHO)
  • Content assignment with uncertainty (mass balance approach, assay)
  • Retest period, stability, re-qualification, replacement
  • Sources of reference standards and responsibilities of the user
  • Appropriate use of reference standards in GMP testing

Who Will Benefit:

  • Analysts 
  • Lab Supervisors and Managers in Quality Control and Analytical Development
  • Quality Assurance
  • Regulatory Affairs, and inspection functions interested to gain an overview on GMP and compendial requirements with respect to reference standards, as well as practical orientation and recommendations concerning appropriate characterization, use and maintenance in dependence on the type of reference standards. 

Speaker Profile

Dr. Joachim Ermer is a biochemist with 30 years of experience in pharmaceutical analytics, including development products at Hoechst AG, global responsibilities as Director of Analytical Processes and Technology at Aventis, and head of Quality Control and head of QC Lifecycle Management Frankfurt Chemistry at Sanofi. From 2010 till 2020, he was also responsible for the central reference standard group and Global Reference Standard Coordinator of Sanofi. Since December 2020, he serves as consultant for topics of pharmaceutical analytics and Quality Control. Joachim Ermer is member of the USP Expert Committee “Measurement and Data Quality“, of the Ph.Eur. Working Group “Chromatographic Separation Techniques”, and Advisory Board member of the ECA Analytical Quality Control Group.

He authored more than 60 publications on analytical topics and contributed to the USP General Information Chapter <1220> as well as other Stimuli Articles. He is editor and author of the book “Method Validation in Pharmaceutical Analysis. A Guide to Best Practice” (Wiley-VCH, 2005, 2015, 2024).